CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-12 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,146 | $74.44 | $85K | 61,174 |
| 2024-03-12 | Kulkarni Samarth Chief Executive Officer | Sale | −4,583 | $74.44 | $341K | 208,122 |
| 2024-03-11 | KASINGER JAMES R. General Counsel and Secretary | Sale | −2,801 | $78.26 | $219K | 60,070 |
| 2024-03-11 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +2,250 | 62,320 | ||
| 2024-03-11 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −2,250 | 2,250 | ||
| 2024-03-11 | Kulkarni Samarth Chief Executive Officer | Sale | −9,802 | $78.26 | $767K | 203,705 |
| 2024-03-11 | Kulkarni Samarth Chief Executive Officer | Option exercise | +9,000 | 212,705 | ||
| 2024-03-11 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −9,000 | 9,000 | ||
| 2024-03-10 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +5,500 | 62,871 | ||
| 2024-03-10 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −5,500 | 16,500 | ||
| 2024-03-10 | Kulkarni Samarth Chief Executive Officer | Option exercise | +19,250 | 213,507 | ||
| 2024-03-10 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −19,250 | 57,750 | ||
| 2024-02-27 | George Simeon Director | Grant or award | +63,177 | $71.50 | $4.5M | 63,177 |
| 2024-02-27 | George Simeon Director | Grant or award | +216,578 | $71.50 | $15.5M | 216,578 |
| 2024-02-27 | George Simeon Director | Grant or award | +769,196 | $71.50 | $55.0M | 769,196 |
| 2024-02-20 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,913 | $79.67 | $152K | 57,371 |
| 2024-02-20 | Kulkarni Samarth Chief Executive Officer | Sale | −6,370 | $79.67 | $507K | 194,257 |
| 2024-02-18 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +3,825 | 59,284 | ||
| 2024-02-18 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −3,825 | 7,650 | ||
| 2024-02-18 | Kulkarni Samarth Chief Executive Officer | Option exercise | +13,250 | 200,627 |
Page 14 of 46 · 910 trades